If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

RLYB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.80%

Insider Buying (Last 12 Months): $24,120.00

Insider Selling (Last 12 Months): $5,915,500.00

Rallybio Insider Trading History Chart

Rallybio Share Price & Price History

^$6.45

▼ -0.33 (-4.87%)

As of 02/3/2023 10:04 PM ET

Days: 30 | 90 | 365

Know Your Profit Potential BEFORE You Trade!

From Tradewins | Ad

I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital.

Click here for a free copy now!

Click Here to Learn More

Rallybio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/3/2022	Kush Parmar	Director	Sell	150,000	$12.50	$1,875,000.00	1,251,755
5/23/2022	Kush Parmar	Director	Sell	100,000	$13.00	$1,300,000.00	1,302,084
3/21/2022	Jeffrey M. Fryer	Insider	Buy	3,000	$8.04	$24,120.00
2/8/2022	Opportunities I L.P. 5Am	Major Shareholder	Sell	210,000	$13.05	$2,740,500.00
1/19/2022	Jeffrey M. Fryer	Insider	Buy	1,400	$8.70	$12,180.00
1/12/2022	Stephen Uden	Insider	Buy	5,000	$10.55	$52,750.00
1/10/2022	Martin Mackay	CEO	Buy	5,504	$10.10	$55,590.40
1/7/2022	Jeffrey M. Fryer	Insider	Buy	10,000	$9.41	$94,100.00

Know Your Profit Potential BEFORE You Trade!

From Tradewins | Ad

Click Here to Learn More

SEC Filings (Institutional Ownership Changes) for Rallybio (NASDAQ:RLYB)

91.97% of Rallybio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Rallybio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/1/2023	Canaan Partners XI LLC	2,059,712	$13.53M	10.6%	-14.5%	6.431%
11/15/2022	State Street Corp	252,592	$3.66M	0.0%	+1.5%	0.788%
11/15/2022	Northeast Financial Consultants Inc	13,066	$0.19M	0.0%	N/A	0.041%
11/15/2022	Vanguard Group Inc.	798,636	$11.56M	0.0%	+14.7%	2.493%
11/15/2022	BlackRock Inc.	985,375	$14.26M	0.0%	+6.0%	3.076%
11/14/2022	Nuveen Asset Management LLC	22,404	$0.32M	0.0%	-14.2%	0.070%
11/14/2022	MetLife Investment Management LLC	10,279	$0.15M	0.0%	N/A	0.032%
11/10/2022	Dimensional Fund Advisors LP	23,166	$0.34M	0.0%	N/A	0.072%
11/8/2022	New York State Common Retirement Fund	10,337	$0.15M	0.0%	-19.8%	0.032%
11/1/2022	Tekla Capital Management LLC	1,740,931	$25.19M	1.0%	-9.8%	5.418%
8/18/2022	Goldman Sachs Group Inc.	37,838	$0.29M	0.0%	+147.5%	0.118%
8/15/2022	State Street Corp	248,950	$1.88M	0.0%	+57.0%	0.775%
8/15/2022	Laurion Capital Management LP	402,000	$3.04M	0.0%	+0.5%	1.251%
8/15/2022	Millennium Management LLC	18,195	$0.14M	0.0%	-27.5%	0.057%
8/13/2022	American International Group Inc.	7,466	$56K	0.0%	-16.9%	0.023%
8/12/2022	Northern Trust Corp	116,234	$0.88M	0.0%	-11.6%	0.362%
8/12/2022	FMR LLC	2,893,557	$21.85M	0.0%	0.0%	9.006%
8/12/2022	Rhumbline Advisers	19,190	$0.15M	0.0%	+47.7%	0.060%
8/11/2022	Alps Advisors Inc.	19,060	$0.14M	0.0%	N/A	0.059%
8/11/2022	JPMorgan Chase & Co.	10,009	$75K	0.0%	-19.1%	0.031%
7/29/2022	Tekla Capital Management LLC	1,931,120	$14.58M	0.6%	-12.0%	6.010%
5/27/2022	Walleye Capital LLC	59,543	$0.42M	0.0%	N/A	0.185%
5/17/2022	Walleye Capital LLC	59,543	$0.42M	0.0%	N/A	0.185%
5/16/2022	California State Teachers Retirement System	7,694	$54K	0.0%	+124.8%	0.024%
5/16/2022	Goldman Sachs Group Inc.	15,289	$0.11M	0.0%	+17.0%	0.048%
5/16/2022	State Street Corp	158,573	$1.11M	0.0%	+114.8%	0.494%
5/16/2022	Novo Holdings A S	435,944	$3.04M	0.1%	N/A	1.357%
5/13/2022	Renaissance Technologies LLC	52,715	$0.37M	0.0%	N/A	0.164%
5/13/2022	Northern Trust Corp	131,432	$0.92M	0.0%	+113.5%	0.409%
5/13/2022	Charles Schwab Investment Management Inc.	45,581	$0.32M	0.0%	+183.5%	0.142%
5/13/2022	American International Group Inc.	8,984	$63K	0.0%	+134.9%	0.028%
5/13/2022	Tekla Capital Management LLC	2,195,010	$15.32M	0.5%	-4.9%	6.832%
5/13/2022	Vanguard Group Inc.	710,049	$4.96M	0.0%	+122.0%	2.210%
5/12/2022	BlackRock Inc.	908,164	$6.34M	0.0%	+88.6%	2.826%
5/12/2022	Rhumbline Advisers	12,995	$91K	0.0%	N/A	0.040%
5/11/2022	Bank of New York Mellon Corp	41,688	$0.29M	0.0%	+145.6%	0.130%
5/11/2022	JPMorgan Chase & Co.	12,374	$86K	0.0%	-96.2%	0.039%
5/10/2022	Sectoral Asset Management Inc.	385,069	$2.69M	0.5%	+27.8%	1.198%
2/9/2022	AJU IB Investment Co. Ltd.	754,678	$7.20M	10.0%	N/A	2.349%
2/8/2022	Northern Trust Corp	61,571	$0.59M	0.0%	+7.1%	0.192%
2/3/2022	Canaan Partners XI LLC	2,409,712	$22.99M	5.9%	N/A	7.500%
1/28/2022	Allspring Global Investments Holdings LLC	2,914	$27K	0.0%	N/A	0.009%
11/16/2021	Laurion Capital Management LP	400,000	$7.03M	0.0%	N/A	1.245%
11/15/2021	Viking Global Investors LP	4,194,777	$73.74M	0.2%	N/A	13.056%
11/15/2021	Sectoral Asset Management Inc	527,136	$9.27M	0.8%	N/A	1.641%
11/15/2021	Caas Capital Management LP	10,000	$0.18M	0.0%	N/A	0.031%
11/12/2021	New Leaf Venture Partners L.L.C.	2,301,603	$40.46M	11.7%	N/A	7.163%
11/12/2021	Geode Capital Management LLC	69,963	$1.23M	0.0%	N/A	0.218%
11/9/2021	BlackRock Inc.	292,204	$5.14M	0.0%	N/A	0.909%
11/4/2021	Deutsche Bank AG	4,139	$73K	0.0%	N/A	0.013%
11/2/2021	New York State Common Retirement Fund	4,396	$77K	0.0%	N/A	0.014%

Data available starting January 2016

Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclonal anti-HPA-1a antibody that is in a Phase 1/2 clinical trial for the prevention of FNAIT; RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases; and RLYB116, a subcutaneously administered inhibitor of C5 for the treatment of patients with paroxysmal nocturnal hemoglobinuria and generalized myasthenia gravis. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut.

Today's Range

Now: $6.45

$6.28

$6.85

50 Day Range

MA: $6.16

$4.67

$8.00

52 Week Range

Now: $6.45

$4.54

$15.89

Volume

81,400 shs

Average Volume

55,939 shs

Market Capitalization

$206.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Rallybio?: Rallybio's top insider investors include:
Kush Parmar (Director)
Jeffrey M Fryer (Insider)
Martin Mackay (CEO)
Opportunities I LP 5Am (Major Shareholder)
Stephen Uden (Insider)
Learn More about top insider investors at Rallybio.
Who are the major institutional investors of Rallybio?: Rallybio's top institutional investors include:
Canaan Partners XI LLC — 6.43%
Learn More about top institutional investors of Rallybio stock.
Which institutional investors are selling Rallybio stock?: In the last quarter, RLYB stock was sold by these institutional investors:
Canaan Partners XI LLC
Within the previous year, company insiders that have sold Rallybio company stock include:
Kush Parmar (Director)
Jeffrey M Fryer (Insider)
Learn More investors selling Rallybio stock.

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

RLYB Insider Trading

Rallybio Insider Trading History Chart

Rallybio Share Price & Price History

Rallybio Insider Trading History

SEC Filings (Institutional Ownership Changes) for Rallybio (NASDAQ:RLYB)

Institutional Buying and Selling by Quarter

Rallybio Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Rallybio?

Who are the major institutional investors of Rallybio?

Which institutional investors are selling Rallybio stock?